超重患者的药物治疗。 - Suppr

Suppr

超能文献

Pharmacological treatment of the overweight patient.

作者信息

Bray George A, Greenway Frank L

机构信息

Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA.

出版信息

Pharmacol Rev. 2007 Jun;59(2):151-84. doi: 10.1124/pr.59.2.2.

DOI:10.1124/pr.59.2.2

PMID:17540905

Abstract

摘要

相似文献

Pharmacological treatment of the overweight patient.

Pharmacol Rev. 2007 Jun;59(2):151-84. doi: 10.1124/pr.59.2.2.

Pharmacological treatment of obesity in Europe: waiting for the arrival of the white blackbird.

Endocrinol Nutr. 2014 Dec;61(10):501-4. doi: 10.1016/j.endonu.2014.11.002.

Pharmacological and surgical treatments for obesity.

Am Heart J. 2006 Mar;151(3):604-24. doi: 10.1016/j.ahj.2005.03.007.

ACS chemical neuroscience molecule spotlight on Qnexa.

ACS Chem Neurosci. 2011 Apr 20;2(4):183-4. doi: 10.1021/cn200023v.

Pharmacological therapies for obesity.

Gastroenterol Clin North Am. 2005 Mar;34(1):91-104. doi: 10.1016/j.gtc.2004.12.002.

Medications for weight reduction.

Med Clin North Am. 2011 Sep;95(5):989-1008. doi: 10.1016/j.mcna.2011.06.009.

Updates on obesity pharmacotherapy.

Ann N Y Acad Sci. 2018 Jan;1411(1):106-119. doi: 10.1111/nyas.13542.

The pharmacologic management of obesity.

J Fla Med Assoc. 1997 Feb;84(2):89-92.

Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors.

Obesity (Silver Spring). 2006 Jun;14 Suppl 3:143S-149S. doi: 10.1038/oby.2006.294.

New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia).

Cardiol Rev. 2014 Jan-Feb;22(1):43-50. doi: 10.1097/CRD.0000000000000001.

引用本文的文献

Pharmacologic Treatment of Obesity in adults and its impact on comorbidities: 2024 Update and Position Statement of Specialists from the Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso) and the Brazilian Society of Endocrinology and Metabolism (SBEM).

Arch Endocrinol Metab. 2024 Nov 25;68:e240422. doi: 10.20945/2359-4292-2024-0422. eCollection 2024.

Comprehensive Role of GDF15 in Inhibiting Adipogenesis and Hyperlipidemia, Enhancing Cardiovascular Health and Alleviating Inflammation in Metabolic Disorders.

Curr Pharm Des. 2024;30(30):2387-2399. doi: 10.2174/0113816128318741240611114448.

Phentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatment?

Curr Obes Rep. 2024 Mar;13(1):132-140. doi: 10.1007/s13679-023-00546-9. Epub 2024 Jan 3.

Encapsulated Peptides and Proteins with an Effect on Satiety.

Nanomaterials (Basel). 2023 Mar 24;13(7):1166. doi: 10.3390/nano13071166.

Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities.

Pharmaceutics. 2022 Jul 11;14(7):1445. doi: 10.3390/pharmaceutics14071445.

Metformin Intervention-A Panacea for Cancer Treatment?

Cancers (Basel). 2022 Mar 4;14(5):1336. doi: 10.3390/cancers14051336.

Energy imbalance: obesity, associated comorbidities, prevention, management and public health implications.

Adv Obes Weight Manag Control. 2020;10(5):146-161. Epub 2020 Oct 29.

Growth differentiation factor 15 as a potential therapeutic for treating obesity.

Mol Metab. 2021 Apr;46:101117. doi: 10.1016/j.molmet.2020.101117. Epub 2020 Nov 18.

Antiobesity effects of seedlac and shellac in rats fed with a high-fat diet.

Res Pharm Sci. 2020 Feb 20;15(1):57-65. doi: 10.4103/1735-5362.278715. eCollection 2020 Feb.

Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial.

Sci Rep. 2019 Nov 28;9(1):17833. doi: 10.1038/s41598-019-54436-z.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Pharmacological treatment of the overweight patient.

作者信息

Bray George A, Greenway Frank L

机构信息

Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA.

出版信息

Pharmacol Rev. 2007 Jun;59(2):151-84. doi: 10.1124/pr.59.2.2.

DOI:10.1124/pr.59.2.2

PMID:17540905

Abstract

摘要

相似文献

Pharmacological treatment of the overweight patient.

Pharmacol Rev. 2007 Jun;59(2):151-84. doi: 10.1124/pr.59.2.2.

Pharmacological treatment of obesity in Europe: waiting for the arrival of the white blackbird.

Endocrinol Nutr. 2014 Dec;61(10):501-4. doi: 10.1016/j.endonu.2014.11.002.

Pharmacological and surgical treatments for obesity.

Am Heart J. 2006 Mar;151(3):604-24. doi: 10.1016/j.ahj.2005.03.007.

ACS chemical neuroscience molecule spotlight on Qnexa.

ACS Chem Neurosci. 2011 Apr 20;2(4):183-4. doi: 10.1021/cn200023v.

Pharmacological therapies for obesity.

Gastroenterol Clin North Am. 2005 Mar;34(1):91-104. doi: 10.1016/j.gtc.2004.12.002.

Medications for weight reduction.

Med Clin North Am. 2011 Sep;95(5):989-1008. doi: 10.1016/j.mcna.2011.06.009.

Updates on obesity pharmacotherapy.

Ann N Y Acad Sci. 2018 Jan;1411(1):106-119. doi: 10.1111/nyas.13542.

The pharmacologic management of obesity.

J Fla Med Assoc. 1997 Feb;84(2):89-92.

Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors.

Obesity (Silver Spring). 2006 Jun;14 Suppl 3:143S-149S. doi: 10.1038/oby.2006.294.

New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia).

Cardiol Rev. 2014 Jan-Feb;22(1):43-50. doi: 10.1097/CRD.0000000000000001.

引用本文的文献

Arch Endocrinol Metab. 2024 Nov 25;68:e240422. doi: 10.20945/2359-4292-2024-0422. eCollection 2024.

Comprehensive Role of GDF15 in Inhibiting Adipogenesis and Hyperlipidemia, Enhancing Cardiovascular Health and Alleviating Inflammation in Metabolic Disorders.

Curr Pharm Des. 2024;30(30):2387-2399. doi: 10.2174/0113816128318741240611114448.

Phentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatment?

Curr Obes Rep. 2024 Mar;13(1):132-140. doi: 10.1007/s13679-023-00546-9. Epub 2024 Jan 3.

Encapsulated Peptides and Proteins with an Effect on Satiety.

Nanomaterials (Basel). 2023 Mar 24;13(7):1166. doi: 10.3390/nano13071166.

Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities.

Pharmaceutics. 2022 Jul 11;14(7):1445. doi: 10.3390/pharmaceutics14071445.

Metformin Intervention-A Panacea for Cancer Treatment?

Cancers (Basel). 2022 Mar 4;14(5):1336. doi: 10.3390/cancers14051336.

Energy imbalance: obesity, associated comorbidities, prevention, management and public health implications.

Adv Obes Weight Manag Control. 2020;10(5):146-161. Epub 2020 Oct 29.

Growth differentiation factor 15 as a potential therapeutic for treating obesity.

Mol Metab. 2021 Apr;46:101117. doi: 10.1016/j.molmet.2020.101117. Epub 2020 Nov 18.

Antiobesity effects of seedlac and shellac in rats fed with a high-fat diet.

Res Pharm Sci. 2020 Feb 20;15(1):57-65. doi: 10.4103/1735-5362.278715. eCollection 2020 Feb.

Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial.

Sci Rep. 2019 Nov 28;9(1):17833. doi: 10.1038/s41598-019-54436-z.